A A A

Eye Therapy News

2 Lazy 2 Run? We’re biking it for blood cancer!

Fri, 29 Aug 2014 09:30:05 +0000

  On Sunday 31 August a group of not so elite athletes from the Gene and Cell Therapy group will be taking part in the London Bikeathon 2014 to raise funds for Leukaemia & Lymphoma Research. The 2 Lazy 2 Run CC will be cycling 52 miles – that’s more than a marathon, no mean feet […]

Read more...

The Art of Eyes

Thu, 07 Aug 2014 14:23:19 +0000

The eye is an object of great beauty as shown by the Ophthalmologist in their July/August 2014 issue. This month’s issue features a photo essay called The Art of the Eyes and includes examples of the work from a number research labs capturing the complex and beautiful detail of the eye and its cells. The essay includes images […]

Read more...

In memoriam

Tue, 05 Aug 2014 16:02:34 +0000

Dr Yoshiki Sasai (1962 – 2014) It is with great sadness today that we remember and pay tribute to our collaborator Dr Yoshiki Sasai. Yoshiki was a world leading stem cell researcher and Deputy Director of the Riken Center for Developmental Biology in Kobe, Japan. Through his hard work and dedication over many years, Yoshiki […]

Read more...

International Clinical Trials Day: Our Work in Summary

Tue, 20 May 2014 15:03:41 +0000

Introduction Today, 20 May 2014, is International Clinical Trials Day. This landmark day remembers the pioneering work of James Lind a Scottish naval physician who, in the 1700s, conducted the first controlled clinical study that identified that citrus fruit (containing Vitamin C) was effective in treating scurvy. Each year, a number of organisations mark this […]

Read more...

Retina patient day 2012

We held the first “Retina Patient Day” in London on April 21st 2012. Over 250 people with retinal degeneration and their family members met with more than 40 clinicians and scientists from UCL Institute of Ophthalmology Department of Genetics and Moorfields Eye Hospital Biomedical Research Centre for Ophthalmology, who provided updates on their research into developing effective treatments for blinding retinal conditions.

We began he day with a series of short talks delivered by the senior investigators leading the research effort. Professors Robin Ali, James Bainbridge and Tony Moore were joined by Drs. Lyndon da Cruz, Michel Michaelides, Rachael Pearson and Andrew Webster in setting out how laboratory and clinical studies are rapidly enhancing our understanding of how best to treat inherited diseases that cause blindness.

Our researchers spoke about how the advances we have made in basic science are gradually being translated into clinical trials – we told the attendees that with further rigorous work more effective treatments could be developed in time.

Attendees at the Retina Patient Day appreciated the unique opportunity to interact with dozens of our clinicians and scientists, which we arranged in four broad ways: information stalls, a chance to ‘meet the doctor’, ‘meet the scientist’ and ‘meet the counsellor,’ an artist’s workshop, and most importantly, over 30 poster presentations explaining our research in terms that attendees could relate to. Our researchers presented their posters and explained how their area of research fits into the broader effort of seeking therapies for visual disorders; they answered many excellent questions put to them by the attendees, who were keen to understand more about their conditions and about the research into treatments.

This opportunity to engage with scientists at the forefront of delivering innovative therapies is not often afforded to people with vision loss, and the interaction proved very welcome. 

Some feedback from attendees

‘Very enlightening and educational, really delighted this patient day has been put on. Worth travelling from S.Wales!!!’

‘Extremely informative, one to one discussions with the professionals. Definitely will come again’

‘Well organised event with very helpful speakers. Like the poster rooms for specific questions’

Following these fruitful and energetic interactive sessions, we brought to a close with an insight into the work of RP Fighting Blindness and Moorfields Eye Charity, two of the organisations whose generous support make the research being discussed (and the awareness day itself) possible.

Attendees were also given an opportunity throughout the day to submit questions to the lead investigators – these questions covered a range of topics and were answered by our panel of experts in the final plenary session.

Our Retina Patient Day 2012 proved an excellent opportunity for patients with retinal degeneration and their families to engage with researchers involved in developing new treatments. Commenting on the day, Prof. Robin Ali, Head of Department of Genetics and the BRC Gene Therapy Theme leader, said “The day has been a great success. We aim to hold a “Retina Patient Day” every year. Patient engagement is an essential part of developing an effective translational research programme. Our team not only look forward to further opportunities to explain our work to patients and their families, but to involve and learn from those who may benefit from it in the future.”

Page last modified on 30 nov 12 17:29